Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

RBPMS2 Inhibitors

RBPMS2 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of RNA-binding protein with multiple splicing 2 (RBPMS2). RBPMS2 is part of the RNA-binding protein family, which plays a significant role in post-transcriptional gene regulation. It primarily functions by binding to mRNA and influencing processes such as mRNA stability, splicing, transport, and translation. RBPMS2 is particularly involved in regulating gene expression in smooth muscle cells and tissues associated with the gastrointestinal tract, contributing to the differentiation and maintenance of smooth muscle characteristics. By interacting with mRNA sequences, RBPMS2 modulates the expression of proteins that are critical for maintaining cellular structure and function in these tissues. Inhibitors of RBPMS2 disrupt its ability to bind to mRNA, thereby interfering with its regulatory functions at the post-transcriptional level.

Inhibition of RBPMS2 can lead to significant changes in gene expression patterns, particularly in tissues where this protein plays a central regulatory role. By preventing RBPMS2 from stabilizing and controlling mRNA translation, these inhibitors can alter the production of proteins that are essential for smooth muscle function, leading to broader effects on cellular differentiation and tissue maintenance. Researchers use RBPMS2 inhibitors to study the specific roles of this protein in RNA metabolism and to explore how it contributes to the regulation of gene expression in muscle tissue development. These inhibitors provide valuable insights into the molecular mechanisms that govern post-transcriptional gene regulation, helping scientists understand the complexities of RNA-binding proteins and their impact on cellular processes. Furthermore, RBPMS2 inhibitors serve as important tools for investigating the broader family of RNA-binding proteins, offering clues about how these proteins interact with RNA to control gene expression across different biological systems. Through these studies, researchers can gain a deeper understanding of RNA-protein interactions and their influence on gene expression and cellular function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor could lead to hypomethylation of the RBPMS2 gene promoter, potentially resulting in decreased transcription efficiency and lower protein levels.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

By inhibiting histone deacetylases, Trichostatin A may enhance the acetylation of histones at the RBPMS2 gene, leading to a condensed chromatin state and reduced transcriptional activity.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid might promote hyperacetylation of histones associated with the RBPMS2 gene, which could decrease the gene′s expression by altering chromatin structure to a more closed configuration.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin could inhibit the mTOR pathway, which is crucial for cap-dependent mRNA translation, potentially reducing the translation efficiency of RBPMS2 mRNA.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

By blocking PI3K, LY 294002 may disrupt downstream AKT signaling, leading to decreased transcriptional activity of genes including RBPMS2 by limiting nuclear localization of transcription activators.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib, by inhibiting RAF kinase, could disrupt the MAPK/ERK signaling pathway, which may lead to decreased activation of transcription factors responsible for RBPMS2 gene expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125, a JNK inhibitor, may decrease the phosphorylation of transcription factors that enhance RBPMS2 expression, leading to lower mRNA synthesis.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 may inhibit the proteasomal degradation of specific transcription repressors of the RBPMS2 gene, potentially increasing their availability and decreasing RBPMS2 expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

As a proteasome inhibitor, Bortezomib could increase the cellular levels of transcription repressors that target the RBPMS2 gene, leading to its decreased expression.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Nutlin-3 could stabilize p53 by preventing its degradation via MDM2 inhibition, potentially leading to enhanced transcriptional repression of the RBPMS2 gene.